I am a
Home I AM A Search Login

Papers of the Week


Papers: 22 Jun 2019 - 28 Jun 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 Aug


Cephalalgia


39


9

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.

Authors

Dodick DW, Lipton RB, Silberstein S, Goadsby PJ, Biondi D, Hirman J, Cady R, Smith J
Cephalalgia. 2019 Aug; 39(9):1075-1085.
PMID: 31234642.

Abstract

Calcitonin gene-related peptide plays an important role in migraine pathophysiology. We evaluated eptinezumab, an intravenous (IV) anti-calcitonin gene-related peptide monoclonal antibody, for the prevention of chronic migraine.